Published: Apr 12, 2026
Written by Klarity Editorial Team
Published: Apr 12, 2026

If you’re struggling with Binge Eating Disorder (BED), you may wonder whether you can access treatment through telehealth—especially when it comes to prescription medications like Topamax (topiramate) or Wellbutrin (bupropion). The short answer is yes, and the landscape has never been more accessible. With evolving telehealth regulations and extended federal flexibilities through 2026, getting evidence-based care for BED from the comfort of your home is not only possible—it’s safe, legal, and increasingly common.
This comprehensive guide walks you through everything you need to know about telehealth prescribing for Binge Eating Disorder medications, including federal and state-specific rules, who can prescribe, what medications are available, and how to ensure you’re receiving quality care.
Binge Eating Disorder is the most common eating disorder in the United States, affecting millions of Americans. It’s characterized by recurrent episodes of eating large quantities of food in a short period (typically within two hours), accompanied by a sense of loss of control. Unlike bulimia, BED doesn’t involve compensatory behaviors like purging or excessive exercise.
According to DSM-5 criteria, a diagnosis of BED requires:
While psychotherapy (particularly Cognitive Behavioral Therapy) remains the gold standard for BED treatment, medications can play a valuable supporting role—especially when combined with therapy. That’s where telehealth comes in, making both counseling and medication management more accessible than ever.
Here’s the most important thing to understand: Medications like Topamax and Wellbutrin are not controlled substances. This means they were never subject to the strict federal in-person requirements that apply to controlled medications under the Ryan Haight Act.
The Ryan Haight Act (passed in 2008) requires an in-person medical evaluation before prescribing controlled substances via telemedicine. However, this law only applies to Schedule II–V controlled substances like stimulants, opioids, and benzodiazepines. Non-controlled prescription medications—which include most antidepressants, mood stabilizers, and anticonvulsants used for BED—can be prescribed via telehealth without any federal in-person visit requirement.
While the federal rules for non-controlled medications haven’t changed, it’s worth noting that the DEA has extended COVID-era telehealth flexibilities for controlled substances through December 31, 2026. This fourth extension allows certain controlled medications to be prescribed via telehealth while the DEA finalizes permanent rules.
For BED patients, this is particularly relevant because Vyvanse (lisdexamfetamine), the only FDA-approved medication specifically for BED, is a controlled stimulant. However, most telehealth platforms focus on non-controlled alternatives like topiramate and bupropion due to the regulatory complexity and abuse potential of stimulants. If you’re working with a telehealth provider, expect them to recommend non-controlled options first.
What it is: An anticonvulsant medication FDA-approved for seizures and migraine prevention, but commonly used off-label for Binge Eating Disorder.
How it helps with BED: Research suggests topiramate can reduce binge frequency and promote weight loss in some patients. It may work by affecting neurotransmitters that regulate appetite and impulse control.
Telehealth availability: ✅ Fully available nationwide via telehealth. No in-person visit required federally or in most states.
Typical dosing: Usually started at low doses (25mg) and gradually increased to minimize side effects. Treatment doses for BED typically range from 75–200mg daily.
Important safety considerations:
What it is: An atypical antidepressant FDA-approved for depression and smoking cessation, used off-label for BED.
How it helps with BED: Bupropion affects dopamine and norepinephrine pathways, which may help reduce binge eating urges and support mood regulation in patients with concurrent depression.
Telehealth availability: ✅ Fully available nationwide via telehealth. No in-person visit required.
Typical dosing: Extended-release formulations are preferred. Doses typically range from 150–300mg daily.
Important safety considerations:
You might wonder why providers prescribe medications ‘off-label’ for BED. This practice is not only legal but extremely common in medicine. The FDA approves medications for specific conditions based on clinical trials, but doctors can legally prescribe approved medications for any condition they believe will benefit from treatment.
For BED specifically, while only Vyvanse has FDA approval for the condition, clinical research supports the use of topiramate and bupropion. Your telehealth provider should explain why they’re recommending a particular medication, discuss the evidence base, and obtain your informed consent for off-label use. This is standard medical practice and nothing to be concerned about.
While federal law permits telehealth prescribing of non-controlled medications, each state has its own additional requirements. Here’s what you need to know about the states with the largest populations and most varied regulations:
CaliforniaCalifornia leads the nation in telehealth-friendly policies. The state explicitly allows prescribing ‘dangerous drugs’ (prescription medications) via telehealth without any in-person exam requirement, as long as the standard of care is met. In 2025, California passed AB 1503, which clarified that even asynchronous telehealth (questionnaire-based evaluations) can constitute a valid ‘good faith exam’ for prescribing when appropriate.
New YorkNew York has no in-person requirement for non-controlled medications. While the state adopted new rules in May 2025 requiring in-person exams for controlled substances (once federal waivers end), these rules explicitly exempt non-controlled medications. Nurse practitioners in New York have full practice authority after completing 3,600 supervised hours.
TexasDespite being a more conservative state regarding telehealth in some respects, Texas allows teleprescribing of non-controlled medications without in-person visits. The state does restrict certain Schedule II controlled substances, but Topamax and Wellbutrin can be prescribed entirely via telehealth. Note that Texas requires NPs and PAs to work under collaborative agreements with physicians, but this happens behind the scenes and shouldn’t affect your access to care.
DelawareDelaware’s Telehealth Act allows fully remote prescribing for non-controlled medications. The state recently (July 2025) passed SB 101 to clarify that medication-assisted treatment for opioid use disorder can also be provided via telemedicine—demonstrating the state’s progressive stance on telehealth access.
FloridaFlorida permits telehealth prescribing for non-controlled medications without in-person visits. The state does prohibit teleprescribing of most Schedule II controlled substances, but this doesn’t affect BED treatment with Topamax or Wellbutrin.
AlabamaAlabama has a unique ‘4-visit rule.’ If you receive more than four telehealth visits in a 12-month period for the same condition, you must have an in-person visit within that year. However, this can be satisfied by seeing any collaborating provider in person—it doesn’t have to be your telehealth prescriber. This rule was established in Alabama’s 2022 Telehealth Act.
GeorgiaGeorgia requires that patients receiving ongoing telemedicine care have an in-person examination at least annually. The initial evaluation can be done via telehealth if it’s equivalent to an in-person exam, but the state mandates an annual in-person touch point for continued treatment.
New HampshireNew Hampshire recently modernized its telehealth laws (SB 252, effective August 2025). The state now allows telehealth prescribing even for Schedule II–IV controlled substances without an initial in-person visit, but requires an in-person examination at least every 12 months for ongoing controlled substance prescriptions. For non-controlled medications like those used for BED, telehealth is fully permitted.
In most cases, you can start BED medication treatment entirely via telehealth without ever setting foot in a doctor’s office. Even in states like Alabama and Georgia that require periodic in-person visits, this typically applies only to long-term, ongoing treatment—and can often be satisfied by visiting any local healthcare provider for a basic check-up.
The practical reality is that most patients will want periodic in-person care anyway for things like blood work, blood pressure checks, or comprehensive physical exams. The telehealth rules simply ensure you’re not locked into a specific requirement that could create access barriers.
In all 50 states, licensed physicians can prescribe Topamax and Wellbutrin via telehealth as long as they’re licensed in your state and follow appropriate standards of care.
The landscape for nurse practitioner prescribing has changed dramatically in recent years. As of 2025, 34 states plus Washington, D.C. grant nurse practitioners full practice authority—meaning they can evaluate, diagnose, and prescribe medications independently without physician oversight.
States that recently joined the full practice authority list include:
In these states, an NP working for a telehealth platform can provide complete BED care—from diagnosis through prescribing and follow-up—without needing a physician collaborator.
States where NPs need physician collaboration:In states like Texas, Florida, Georgia, and Alabama, NPs must work under a collaborative practice agreement with a physician to prescribe medications. This doesn’t mean you’ll necessarily see the physician—it’s a behind-the-scenes regulatory requirement. The NP conducts your evaluation and prescribes medication, but there’s a supervising physician who oversees the practice.
For patients, this distinction rarely affects the quality or accessibility of care. Whether you see an MD, DO, or NP via telehealth, you should receive the same evidence-based evaluation and treatment.
PAs can prescribe these medications in all states under appropriate supervision arrangements (the specific requirements vary by state, similar to NPs). PAs are valuable members of the telehealth workforce and can provide excellent BED care.
A legitimate telehealth evaluation for BED should be comprehensive—typically 30 minutes or longer for an initial visit. Here’s what you can expect:
Detailed Eating HistoryYour provider will ask specific questions about your eating patterns:
Mental Health AssessmentBED commonly co-occurs with depression, anxiety, and other mental health conditions. Your provider will screen for:
Medical HistoryExpect questions about:
Physical Assessment (Remote)While your provider can’t physically examine you, they can assess:
Many states require telehealth providers to verify your identity and location before prescribing. This isn’t about not trusting you—it’s a regulatory requirement to ensure the provider is licensed in your state and to prevent fraud. You may be asked to show a photo ID and confirm your address.
Your evaluation will be documented in an electronic health record, just like an in-person visit. This documentation should include:
If medication is appropriate, your provider will send an electronic prescription to your pharmacy of choice. For medications like Topamax and Wellbutrin, you’ll typically:
Refill policies: Because these are non-controlled medications, providers can often authorize refills for 6–12 months (depending on state law). However, you’ll still need periodic check-in appointments to monitor your progress and adjust treatment as needed.
Many patients worry about being ‘looked up’ in their state’s prescription monitoring database. Here’s what you need to know:
Prescription Monitoring Programs are state databases that track controlled substance prescriptions. They were created primarily to combat opioid misuse and diversion.
Because Topamax and Wellbutrin are not controlled substances, most states do not require—or even allow—providers to check the PMP before prescribing them. PMP laws typically mandate checks only for Schedule II–IV controlled substances.
Even though it’s not legally required for non-controlled medications, your telehealth provider might review your medication history as part of good clinical practice. They want to ensure:
This is routine medical due diligence, not a judgment. Being honest about all medications and supplements you’re taking helps your provider keep you safe.
The telehealth industry has grown exponentially, and with growth comes variability in quality. High-profile cases—like the 2024 federal indictment of executives from a telehealth ADHD startup for unsafe prescribing practices—have highlighted the importance of choosing legitimate providers.
Guaranteed prescriptions before evaluationIf a service promises you’ll get medication before they’ve even assessed you, that’s a major red flag. Legitimate providers never guarantee prescriptions—they evaluate first, then determine if medication is appropriate.
Superficial evaluationsA 5-minute questionnaire followed by an immediate prescription is not adequate care. BED treatment requires a thorough evaluation of your eating patterns, mental health, medical history, and treatment goals.
No discussion of alternativesMedication is just one tool for BED treatment. Reputable providers will discuss the role of psychotherapy (especially CBT), nutritional counseling, and other interventions. If a provider only offers pills without mentioning therapy, be cautious.
Selling medication directlyLegitimate telehealth services send prescriptions to licensed pharmacies—they don’t sell medication directly from their own ‘pharmacy’ or warehouse. Your prescription should go to CVS, Walgreton, a legitimate mail-order pharmacy, or another established pharmacy.
Avoiding follow-upQuality telehealth requires ongoing monitoring. If a provider gives you a year’s worth of refills with no expectation of follow-up visits, that’s concerning. You should have scheduled check-ins, especially when starting a new medication.
Licensed, credentialed providersThe provider should be a licensed MD, DO, NP, or PA in your state. The service should clearly display provider credentials and license verification.
Comprehensive intake processExpect to spend significant time on your initial evaluation—30 minutes to an hour is typical for a thorough BED assessment.
Informed consentYou should receive clear information about telehealth limitations, privacy practices, and what to do in emergencies. Many states require written telehealth consent forms.
Multidisciplinary approachThe best telehealth platforms offer or coordinate with therapy services, not just medication management. At Klarity Health, for example, our model connects patients with both psychiatric providers for medication management and licensed therapists for evidence-based psychotherapy—because we know BED treatment works best when both approaches are combined.
Transparent pricingWhether you’re using insurance or paying cash, pricing should be clear upfront. Hidden fees or surprise charges are unacceptable.
Insurance and cash optionsQuality platforms should accept both insurance and offer transparent cash-pay rates for those without coverage or who prefer to pay out-of-pocket. This flexibility ensures access regardless of insurance status.
Available customer supportYou should be able to reach someone if you have questions or concerns between visits—whether that’s through a patient portal, messaging system, or phone support.
While telehealth dramatically expands access, it’s not appropriate for everyone. Your telehealth provider will screen for conditions that require in-person care:
Active or recent purging-type eating disordersIf you have current or recent anorexia nervosa or bulimia nervosa, bupropion is contraindicated due to significantly increased seizure risk. Topiramate would be used with extreme caution. You may need specialized eating disorder treatment in person.
Seizure disordersBoth medications can affect seizure threshold. If you have epilepsy or a history of seizures, these medications may not be safe, or you’ll need very careful monitoring that’s best done in person initially.
Pregnancy and breastfeedingTopiramate carries known risks of birth defects and is not recommended during pregnancy. Most telehealth platforms will not prescribe it to pregnant patients or will require effective contraception. Bupropion has a more complex risk-benefit profile in pregnancy and requires careful discussion.
Severe medical instabilityIf your BED has resulted in severe obesity with urgent complications (uncontrolled diabetes, severe hypertension, heart disease), you may need in-person evaluation and more intensive medical management before or alongside telehealth.
Complex psychiatric conditionsIf you’re experiencing active suicidal ideation, psychosis, or severe bipolar disorder, you likely need more intensive psychiatric care than telehealth alone can provide, at least initially.
Even if you start treatment via telehealth, you should see a provider in person if you experience:
Think of telehealth as one tool in your healthcare toolkit—extremely valuable for access and convenience, but not a replacement for all in-person care.
Most insurance plans now cover telehealth visits at the same rate as in-person visits, though this varies by state and plan. Check with your insurance about:
Many telehealth platforms offer transparent cash-pay pricing for those without insurance or who prefer not to use it. Typical costs might include:
At Klarity Health, we accept most major insurance plans and also offer clear cash-pay rates, so you can choose the payment method that works best for your situation. Our transparent pricing means no surprise bills—you know exactly what you’ll pay before your appointment.
The medications themselves are typically affordable:
Brand-name versions (Topamax, Wellbutrin) cost significantly more and usually aren’t necessary—the generics work just as well.
While this guide focuses on medication access via telehealth, it’s important to emphasize that psychotherapy is the gold standard for BED treatment. Cognitive Behavioral Therapy (CBT) specifically designed for eating disorders has the strongest evidence base.
The most effective approach typically combines:
Many telehealth platforms now offer integrated care, connecting you with both prescribers and therapists through a single service. This coordinated approach ensures your medication management and therapy are working together toward your recovery goals.
The telehealth landscape continues to evolve. Here’s what to watch for:
The DEA is expected to publish final rules on telehealth prescribing of controlled substances by the end of 2026. While this primarily affects medications like Vyvanse (the FDA-approved BED medication that’s a controlled stimulant), it will shape the overall regulatory environment for telehealth prescribing.
More states are moving toward full practice authority for nurse practitioners. Alabama and South Carolina have both seen legislative efforts in 2024–2025 to grant NPs independence, though these haven’t yet become law. As more states join this trend, access to telehealth prescribers will continue to expand.
Industry groups and regulators are working on telehealth quality standards to ensure patient safety while preserving access. Expect continued emphasis on:
Telehealth platforms are incorporating better tools for remote monitoring—from apps that track eating patterns to integration with wearable devices. These technologies can help providers better monitor your progress and adjust treatment between visits.
If you’re struggling with Binge Eating Disorder, telehealth offers a accessible, private, and effective way to get the help you need. Here’s how to get started:
Look for services that:
Before your evaluation:
Your provider can only help if they have accurate information. Be open about:
BED recovery takes time. Medication isn’t a quick fix—it’s a tool that works best when combined with therapy and lifestyle changes. Be prepared to:
At Klarity Health, we understand that struggling with Binge Eating Disorder can feel isolating and overwhelming. That’s why we’ve built a telehealth platform designed specifically for accessible, compassionate mental health care—including eating disorder treatment.
What sets Klarity apart:
Quick provider availability: We know you shouldn’t have to wait weeks for help. Most patients can see a provider within days, not months.
Transparent pricing: Whether you’re using insurance or paying cash, you’ll know the cost upfront—no surprise bills.
Insurance and cash-pay flexibility: We accept most major insurance plans and offer clear self-pay rates for those who prefer not to use insurance or don’t have coverage.
Integrated care approach: Our providers can coordinate medication management with therapy referrals, ensuring you get comprehensive care for BED—not just a prescription.
Licensed providers in your state: All our MDs, DOs, and NPs are fully licensed in the states where they practice, ensuring compliance with all telehealth regulations.
If you’re ready to take the first step toward recovery from Binge Eating Disorder, Klarity Health offers a convenient, private way to connect with experienced providers who can help. Our telehealth platform makes it easy to get the medication management and support you need, on your schedule.
The evolution of telehealth regulations has created unprecedented access to effective treatment for Binge Eating Disorder. Whether you live in a rural area without eating disorder specialists, have a busy schedule that makes in-person appointments difficult, or simply prefer the privacy and convenience of virtual care, telehealth offers a legitimate pathway to recovery.
Medications like Topamax and Wellbutrin, while used off-label for BED, have research supporting their effectiveness and can be safely prescribed via telehealth in all 50 states. With clear federal rules confirming that non-controlled medications can be prescribed remotely, and most states adopting telehealth-friendly policies, accessing care has never been easier.
Remember that medication is just one piece of the BED treatment puzzle. The most effective approach typically combines medication with evidence-based psychotherapy, nutritional counseling, and ongoing support. Look for telehealth providers who take a comprehensive approach to your care, not just those offering quick prescriptions.
As we move further into 2026, the telehealth landscape will continue to mature, with improved quality standards, expanding provider availability, and better integration of services. The lessons learned from the pandemic—both the benefits of expanded access and the importance of maintaining safety standards—are shaping a telehealth ecosystem that works for patients.
If you’re struggling with Binge Eating Disorder, don’t let geography, stigma, or access barriers keep you from getting help. Telehealth has made evidence-based treatment available to more people than ever before. Take that first step—your recovery journey can start from wherever you are.
Verified as of: January 4, 2026
This guide reflects the most current telehealth regulations and medical information available as of early 2026:
Federal DEA Rules: COVID-19 telehealth prescribing flexibilities for controlled substances remain in effect through December 31, 2026 (fourth extension). Non-controlled medications were never subject to Ryan Haight Act restrictions and can be prescribed via telehealth without federal in-person requirements.
State Regulations: We verified telehealth prescribing rules for 10+ key states (including AL, CA, DE, FL, GA, NH, NY, TX, MI, WI) using late-2025 legislative updates, state medical board guidance, and authoritative telehealth policy databases.
Source Currency: Over 80% of sources cited are from 2025 or were updated/verified in 2025. Older sources (2024) were used only when confirmed still accurate by newer references.
Pending Developments: Alabama and South Carolina have considered nurse practitioner full practice authority legislation in 2025, but final status is pending confirmation. We’ve noted these as collaborative practice states pending official updates. Monitor the DEA’s pending final rule on telehealth prescribing for controlled substances, expected by end of 2026.
U.S. Department of Health and Human Services. ‘DEA Extends Telemedicine Prescribing Flexibilities Through December 31, 2026.’ HHS Press Release, January 2, 2026. www.hhs.gov
Sheppard Mullin Richter & Hampton LLP. ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Healthcare Law Blog, August 2025. www.sheppardhealthlaw.com
Center for Connected Health Policy (CCHP). ‘State Telehealth Laws & Reimbursement Policies: Online Prescribing.’ Updated November–December 2025. www.cchpca.org
Health Jobs Nationwide. ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ January 2025. blog.healthjobsnationwide.com
U.S. Food and Drug Administration / DailyMed. ‘Bupropion Hydrochloride Extended-Release Tablets – FDA Label.’ Updated 2025. dailymed.nlm.nih.gov
Disclaimer: This guide is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider about your specific situation. Telehealth regulations and medical recommendations may change; verify current rules in your state before making treatment decisions.
Find the right provider for your needs — select your state to find expert care near you.